Fri May 6, 2022 – 4:54 pm EDT
(LifeSiteNews) – The FDA has limited the use of the Johnson and Johnson (J&J) COVID vaccine for adults due to risks of blood clots.
FDA limits use of J&J vaccine due to blood clotting concerns. What happened to “safe” and “effective?”
Great example why censorship of dissenting views is so dangerous. Raising any question about vaccine safety would’ve been labeled “disinformation,” now it’s proven factual. pic.twitter.com/lTp4WnPyPR
— George Gammon (@GeorgeGammon) May 5, 2022
The decision to heavily restrict the use of the jab comes more than a year after a “pause” that was put in place after cases of thrombosis with thrombocytopenia syndrome (TTS) occurred within a week or two have receiving the shot.
TTS is a condition in which you have a low blood platelet count that contributes to clumping and the plugging of blood vessels along with blood clotting. Some blood clots can be fatal as they lead to pulmonary embolisms, heart attacks and strokes.
The AstraZeneca shot was not approved in the U.S. and pulled from the rotation in Canada for similar reasons as the recent downgrading of the J&J offering.
Peter Marks, MD, Ph.D.,
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
